» Articles » PMID: 28025545

The Pathogenetic Effect of Natural and Bacterial Toxins on Atopic Dermatitis

Overview
Journal Toxins (Basel)
Publisher MDPI
Specialty Toxicology
Date 2016 Dec 28
PMID 28025545
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Atopic dermatitis (AD) is a common allergic skin disease that is associated with chronic, recurrent eczematous and pruritic lesions at the flexural folds caused by interacting factors related to environmental and immune system changes. AD results in dry skin, and immunoglobulin E-mediated allergic reactions to foods and environmental allergens. While steroids and anti-histamines temporarily relieve the symptoms of AD, the possibility of side effects from pharmacological interventions remains. Despite intensive research, the underlying mechanisms for AD have not been clarified. A study of established the role of its toxins in the pathogenesis of AD. Approximately 90% of patients with AD experience colonization and up to 50%-60% of the colonizing is toxin-producing. Any damage to the protective skin barrier allows for the entry of invading allergens and pathogens that further drive the pathogenesis of AD. Some natural toxins (or their components) that have therapeutic effects on AD have been studied. In addition, recent studies on inflammasomes as one component of the innate immune system have been carried out. Additionally, studies on the close relationship between the activation of inflammasomes and toxins in AD have been reported. This review highlights the literature that discusses the pathogenesis of AD, the role of toxins in AD, and the positive and negative effects of toxins on AD. Lastly, suggestions are made regarding the role of inflammasomes in AD.

Citing Articles

Atopy in chronic urticaria: an important yet overlooked issue.

Chen Q, Yang X, Ni B, Song Z Front Immunol. 2024; 15:1279976.

PMID: 38380314 PMC: 10876790. DOI: 10.3389/fimmu.2024.1279976.


Temporal relationships between Staphylococcus aureus colonization, filaggrin expression, and pediatric atopic dermatitis.

Dahal A, Chang W, Almasri C, Johansson E, Hurd M, Velasquez V Allergy. 2023; 79(1):104-115.

PMID: 37650296 PMC: 11190941. DOI: 10.1111/all.15871.


Atopic dermatitis-derived strains: what makes them special in the interplay with the host.

Conte A, Brunetti F, Marazzato M, Longhi C, Maurizi L, Raponi G Front Cell Infect Microbiol. 2023; 13:1194254.

PMID: 37389215 PMC: 10303148. DOI: 10.3389/fcimb.2023.1194254.


Zn-MOF hydrogel: regulation of ROS-mediated inflammatory microenvironment for treatment of atopic dermatitis.

Qiu L, Ouyang C, Zhang W, Liu J, Yu L, Chen G J Nanobiotechnology. 2023; 21(1):163.

PMID: 37218019 PMC: 10204188. DOI: 10.1186/s12951-023-01924-0.


Expression of interleukin-1β, interleukin-4, interferon-γ and tumour necrosis factor α in different tissue in a dinitrochlorobenzene-induced ear swelling test in mice.

Li C, Liu N Skin Res Technol. 2023; 29(1):e13255.

PMID: 36704886 PMC: 9838767. DOI: 10.1111/srt.13255.


References
1.
Gu S, Yang A, Xue C, Li C, Pang C, Zhang W . Chinese herbal medicine for atopic eczema. Cochrane Database Syst Rev. 2013; (9):CD008642. PMC: 10639001. DOI: 10.1002/14651858.CD008642.pub2. View

2.
Ezepchuk Y, Leung D, Middleton M, Bina P, REISER R, Norris D . Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes. J Invest Dermatol. 1996; 107(4):603-9. DOI: 10.1111/1523-1747.ep12583377. View

3.
Craven R, Gao X, Allen I, Gris D, Bubeck Wardenburg J, McElvania-TeKippe E . Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS One. 2009; 4(10):e7446. PMC: 2758589. DOI: 10.1371/journal.pone.0007446. View

4.
Howell M, Fairchild H, Kim B, Bin L, Boguniewicz M, Redzic J . Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol. 2008; 128(9):2248-58. DOI: 10.1038/jid.2008.74. View

5.
Harvima I, Nilsson G . Mast cells as regulators of skin inflammation and immunity. Acta Derm Venereol. 2011; 91(6):644-50. DOI: 10.2340/00015555-1197. View